Literature DB >> 21435017

Peri-implant bone reactions to immediate implants placed at different levels in relation to crestal bone. Part I: a pilot study in dogs.

Bruno Negri1, Jose Luis Calvo-Guirado1, Guillermo Pardo-Zamora1, Ma Piedad Ramírez-Fernández1, Rafael Arcesio Delgado-Ruíz1, Fernando Muñoz-Guzón1.   

Abstract

PURPOSE: The aim of the present study was to evaluate bone remodeling and bone-to-implant contact (BIC) after immediate placement at different levels in relation to the crestal bone of Beagle dogs.
MATERIALS AND METHODS: The mandibular bilateral second, third and fourth premolars of six Beagle dogs were extracted and six implants were immediately placed in the hemi-arches of each dog. Randomly, three cylindrical and three tapered implants were inserted crestally (control group) and 2 mm subcrestally (experimental group). Both groups were treated with a minimal mucoperiosteal flap elevation approach. A gap from the buccal cortical wall to the implant was always left. Three dogs were allowed a 4-week submerged healing period and the other three an 8-week submerged healing period. The animals were sacrificed and biopsies were obtained. Biopsies were processed for ground sectioning. Histomorphometric analysis was carried out in order to compare buccal and lingual bone height loss, and BIC between the two groups.
RESULTS: All implants osseointegrated clinically and histologically. Healing patterns examined microscopically at 4 and 8 weeks for both groups (crestal and subcrestal) yielded similar qualitative bone findings. The distance from the top of the implant collar to the first BIC in the lingual crest (A-Lc) showed a significant difference (P=0.0313): 1.91 ± 0.2 mm in the control group and 1.08 ± 0.2 mm in the experimental group. There was less bone resorption in subcrestal implants than crestal implants. The mean percentage of newly formed BIC was greater with the cylindrical implant design (46.06 ± 4.09%) than with the tapered design (32.64 ± 3.72%).
CONCLUSION: These findings suggest that apical positioning of the top of the implant does not jeopardize bone crest and peri-implant tissue remodeling. However, less resorption of the Lc may be expected when implants are placed 2 mm subcrestally.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21435017     DOI: 10.1111/j.1600-0501.2011.02158.x

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  4 in total

1.  Evaluation of a New Dental Implant Cervical Design in Comparison with a Conventional Design in an Experimental American Foxhound Model.

Authors:  Maria Ángeles Pérez-Albacete Martínez; Carlos Pérez-Albacete Martínez; José Eduardo Maté Sánchez De Val; María Luisa Ramos Oltra; Manuel Fernández Domínguez; Jose Luis Calvo Guirado
Journal:  Materials (Basel)       Date:  2018-03-21       Impact factor: 3.623

2.  Narrow- versus mini-implants at crestal and subcrestal bone levels. Experimental study in beagle dogs at three months.

Authors:  José Luis Calvo-Guirado; Carlos Pérez-Albacete; Antonio Aguilar-Salvatierra; José E de Val Maté-Sánchez; Rafael A Delgado-Ruiz; Marcus Abboud; Eugenio Velasco; Gerardo Gómez-Moreno; Georgios E Romanos
Journal:  Clin Oral Investig       Date:  2014-12-11       Impact factor: 3.573

3.  Biomechanical and histological evaluation of four different titanium implant surface modifications: an experimental study in the rabbit tibia.

Authors:  José Luis Calvo-Guirado; Marta Satorres; Bruno Negri; Piedad Ramirez-Fernandez; Jose Eduardo Maté-Sánchez de Val; Jose Eduardo Maté-Sánchez; Rafael Delgado-Ruiz; Gerardo Gomez-Moreno; Marcus Abboud; Georgios E Romanos
Journal:  Clin Oral Investig       Date:  2013-10-18       Impact factor: 3.573

4.  A staged approach of implant placement in immediate extraction sockets for preservation of peri-implant soft and hard tissue.

Authors:  Dileep Nag Vinnakota; Sreenivasa Rao Akula; V Vamsi Krishna Reddy; V Vijay Sankar
Journal:  J Indian Soc Periodontol       Date:  2014-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.